Loading...
NPI 1164522165 · San Francisco, CA · Allergy & Immunology (Internal Medicine) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Roger Wang is a allergy & immunology (internal medicine) physician provider located in San Francisco, California. This profile covers 11 Medicare and 27 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Roger Wang |
| Address | 950 Stockton St |
| City | San Francisco |
| State | CA |
| ZIP | 94108 |
| Taxonomy | Allergy & Immunology (Internal Medicine) Physician |
| NPI Enumerated | September 22, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $648.9K |
| Medicare | $597.4K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
11 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J7331 | Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | 10,180 | $20 | $183.2K |
| 20610 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 1,290 | $90 | $119.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 980 | $120 | $117.2K |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 1,290 | $60 | $75K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 670 | $50 | $36.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 200 | $170 | $34.1K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 60 | $200 | $11.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $150 | $8.2K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 760 | $10 | $4.6K |
| 20600 | In this procedure, the provider inserts a needle through the skin of a patient and into a small joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 20 | $60 | $1.4K |
Showing 1–10 of 11
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 11 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
11 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J7331 | 2 | 60 | 2,200 | $10 | $51.1K |
| 99214 | 1,639 | 37,970 | 120 | $90 | $23.2K |
| 99215 | 2,062 | 15,360 | 50 | $130 | $14.4K |
| J7321 | 2 | 230 | 110 | $60 | $11.1K |
| 99205 | 1,765 | 8,360 | 30 | $170 | $7.2K |
| 99204 | 6,874 | 19,360 | 40 | $120 | $7.2K |
| 20610 | 13 | 2,790 | 50 | $50 | $6K |
| 99212 | 105 | 7,970 | 30 | $40 | $3.4K |
| 20605 | 379 | 450 | 30 | $40 | $2K |
| 20600 | 296 | 500 | 30 | $40 | $1.8K |
Showing 1–10 of 11
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
27 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 20610 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 5,910 | $30 | $177.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 5,660 | $30 | $164.3K |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 660 | $180 | $117K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 1,590 | $50 | $71.5K |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 370 | $170 | $63.8K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 3,010 | $10 | $27.1K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 1,790 | $10 | $12.5K |
| 94760 | The provider takes a single measurement of the patient’s oxygen saturation using a sensor on the ear or finger. | 4,110 | $1 | $8.2K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 620 | $10 | $5.6K |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 2,050 | $1 | $4.1K |
Showing 1–10 of 27
How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. California median
27 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 95165 | In this procedure, the provider mixes and prepares the antigens for allergen immunotherapy. Use this code when the provider prepares one or more antigens. | 6 | 50 | 280 | $250 | $239.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,075 | 13,300 | 640 | $40 | $169.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 705 | 4,230 | 210 | $110 | $135K |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 2 | 10 | 250 | $120 | $108.1K |
| 99245 | The provider sees a patient for an office or other outpatient consultation involving evaluation and management (E/M). The E/M involves a high level of medical decision making or the provider spends… | 281 | 340 | 90 | $140 | $73.9K |
| 99244 | The provider sees a patient for an office or other outpatient consultation involving evaluation and management (E/M). The E/M involves a moderate level of medical decision making or the provider… | 694 | 770 | 130 | $90 | $64K |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 11 | 30 | 370 | $70 | $60.5K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 428 | 2,380 | 350 | $20 | $50.3K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 2,501 | 5,600 | 440 | $10 | $44.4K |
| 95115 | The provider injects the patient with allergenic extracts to desensitize the patient to the allergen; the patient receives a single injection during the visit. | 46 | 110 | 750 | $10 | $35.3K |
Showing 1–10 of 27
Other providers in the same ZIP code as Roger Wang, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Anthony Padula | CA | Rheumatology Physician | $1.3M | $0 |
| Jianghui Zhang | CA | Orthopaedic Surgery Physician | $345.9K | $423.9K |
| Jon Yang | CA | Ophthalmology Physician | $399.6K | $0 |
| Joy Meng | CA | Neurology Physician | $340.3K | $0 |
| David Macgregor | CA | Dermatology Physician | $302.4K | $0 |
| Donald Hershman | CA | Podiatrist | $273.7K | $0 |
| Jacob Johnson | CA | Otolaryngology Physician | $205.7K | $0 |
| Clifford Chew | CA | Otolaryngology Physician | $148.8K | $0 |
| Ke Tuan | CA | Obstetrics & Gynecology Physician | $98K | $7.7K |
| David Fong | CA | Podiatrist | $53K | $16K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.